Tonix Pharmaceuticals Holding Corp (TNXP)

[ash111]

TNXP not sure Folks have realized: The ATM agreement allowed for Tonix to sell up to $15 million of common stock, and since all $15 million worth of shares have been sold the agreement has been terminated. In April 2017, Tonix sold 1.8 million shares of common stock through an underwriting agreement with Aegis Capital Corp., which raised net proceeds of approximately $7.2 million. Following the full exercise of the over-allotment option by the underwriters, the total net proceeds raised were approximately $8.3 million. We currently estimate Tonix will end the second quarter of 2017 with approximately $35 million in cash, cash equivalents, and short-term investments, which will be sufficient to fund operations through the announcement of results for the HONOR study.
http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2017/TNXP-Interim-Analysis-for-HONOR-Study-Expected-in-1H18-article/default.aspx?utm_content=bufferc29f2&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

a/o today- TNXP, actually trading under cash, almost zero debt,2.5m-3m Float and 7.5m O/S.

Baker Bros-Must follow for any biotech investor has only 4 new positions: ANAB JNCE BPMX TNXP (largest institutional Investor)

Pres46:
"Quote

Report also shows that TNXP is fully funded into the 2nd half of 2018, enough to get them thru Phase 3 of the studies and back in to favorable position for shareholders.

Shorts are panicking, you tell by the chatter. Will the biggest squeeze in the history of NASDAQ leave them all in tatters? Stay tuned. Time to cover or bash, we all know which option was chosen. Expect to see them selling to the bid early to try to drive a wedge of fear in shareholders. Wont last, wont work with the bigger hands holding now.

Good luck all"

and Finally "Valuation: $235m or $31.46 per basic share" by Edison. http://www.edisoninvestmentresearch.com/research/report/tonix-pharmaceuticals8/preview/

Market Value1
$31,965,331
a/o May 30, 2017

Authorized Shares
15,000,000
a/o May 01, 2017

Outstanding Shares
7,486,026
a/o May 01, 2017